J&J units in pulmonary deals

Three Johnson & Johnson (NYSE:JNJ) units announced pulmonary and respiratory deals on Tuesday, including a licensing deal with Orexo AB (SSE:ORX) and

Read the full 228 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE